Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05573334Not ApplicableCompleted

Vaginal Care System for Menopausal Women With Urinary Tract Infections

Role: collaborator

NCT05472597Enrolling By Invitation

Continuation of the nuMoM2b Heart Health Study

Role: collaborator

NCT04906252Completed

Vfib by ECG or Echo During Cardiac Arrest

Role: collaborator

NCT05293392Not ApplicableCompleted

Improving COVID-19 Vaccine Uptake Among Black and Latino Youth

Role: collaborator

All 4 trials loaded